https://orcid.org/0000-0001-9484-9838
References
- Lieu PT, Heiskala M, Peterson PA, et al. The roles of iron in health and disease. Mol Aspects Med. 2001;22(1-2):1–87.
- Dusek P, Jankovic J, Le W. Iron dysregulation in movement disorders. Neurobiol Dis. 2012;46(1):1–18.
- Kumar N, Rizek P, Jog M. Neuroferritinopathy: pathophysiology, presentation, differential diagnoses and management. Tremor Other Hyperkinet Mov. 2016;6:355.
- Siah CW, Ombiga J, Adams LA, et al. Normal iron metabolism and the pathophysiology of iron overload disorders. Clin Biochem Rev. 2006;27(1):5–16.
- Conrad ME, Umbreit JN. Iron absorption and transport-an update. Am J Hematol. 2000;64(4):287–298.
- Lehn A, Boyle R, Brown H, et al. Neuroferritinopathy. Parkinsonism Relat Disord. 2012;18(8):909–915.
- Crichton RR, Dexter DT, Ward RJ. Brain iron metabolism and its perturbation in neurological diseases. J Neural Transm (Vienna)). 2011;118(3):301–314.
- Ramos P, Santos A, Pinto NR, et al. Iron levels in the human brain: a post-mortem study of anatomical region differences and age-related changes. J Trace Elem Med Biol. 2014;28(1):13–17.
- Ward RJ, Zucca FA, Duyn JH, et al. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 2014;13(10):1045–1060.
- Lhermitte J, Kraus WM, Mc Alpine MA. Original Papers: on the occurrence of abnormal deposits of iron in the brain in Parkinsonism with special reference to its localisation. J Neurol Psychopathol. 1924;5(19):195–208.
- Powell LW, Seckington RC, Deugnier Y. Haemochromatosis. Lancet. 2016;388(10045):706–716.
- Barton JC. Hemochromatosis and iron overload: from bench to clinic. Am J Med Sci. 2013;346(5):403–412.
- Ohta E, Takiyama Y. MRI findings in neuroferritinopathy. Neurol Res Int. 2012;2012:197438.
- Lima TG, Benevides FLN, Esmeraldo Filho FL, et al. Treatment of iron overload syndrome: a general review. Rev Assoc Med Bras. 2019;65(9):1216–1222.